Skip to main content

Table 1 Characteristics of the patients with ESBL-E bacteremia

From: Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

Demographics

 

 Men

270 (62.5)

 Age (mean, range)

70.3, 0-96 y

 Age > 65 y

280 (72.4)

Place of acquisition

 Community acquired

110 (28.4)

 Health care associated bacteremia

137 (35.4)

 Nosocomial

140 (36.2)

Origin of infection

 Urinary

215 (55.3)

 Biliary

49 (12.7)

 Unknown

37 (9.6)

 Intra-abdominal

34 (8.8)

 Pneumonia

28 (7.2)

 Catheter

16 (4.1)

 Other

8 (2.1)

Comorbidity

Diabetes

112 (28.9)

Cancer

111 (28.7)

Ictus

70 (18.1)

Dementia

66 (17.1)

Immunosuppression

65 (16.8)

COPD

65 (17.1)

Chronic renal failure

68 (17.6)

Cardiac failure

56 (14.5)

Liver cirrhosis

44 (11.4)

Metastatic tumor

33 (8.5)

Charlson ≥3

209 (54)

  1. Date are no. (%) of patients; COPD: chronic obstructive pulmonary disease.